Cracking The Code: Understanding Analyst Reviews For Kymera Therapeutics
Cracking The Code: Understanding Analyst Reviews For Kymera Therapeutics
破译代码：了解kymera therapeutics的分析师评论
The standing of Kymera Therapeutics among financial experts...During the last three months, 7 analysts shared their evaluations of Kymera Therapeutics (NASDAQ:KYMR), revealing diverse outlooks from bullish to bearish.
在过去的三个月中，7位分析师分享了他们对Kymera Therapeutics（纳斯达克股票代码：KYMR）的评估，揭示了从看涨到看跌的不同前景。
The following table summarizes their recent ratings, shedding light on the changing sentiments within the past 30 days and comparing them to the preceding months.
下表汇总了他们最近的评级，阐明了过去30天内情绪的变化，并将其与前几个月进行了比较。
Insights from analysts' 12-month price targets are revealed, presenting an average target of $48.86, a high estimate of $65.00, and a low estimate of $36.00. This upward trend is apparent, with the current average reflecting a 26.58% increase from the previous average price target of $38.60.
分析师12个月目标股价的见解已经公布，平均目标股价为48.86美元，最高估计为65.00美元，低估值为36.00美元。这种上升趋势显而易见，当前的平均价格较之前的38.60美元的平均目标股价上涨了26.58％。
Understanding Analyst Ratings: A Comprehensive Breakdown
了解分析师评级：全面细分
The standing of Kymera Therapeutics among financial experts...
通过对分析师近期...
登录免费看全文
登录/注册
资讯热榜
更新时间